Sunrise Medical
This article was originally published in The Gray Sheet
Executive Summary
Nets approximately $81 mil. from an offering of 3 mil. shares of common stock (2.5 mil. in the U.S. and .5 mil. outside the U.S.) at $28.375 per share. The company initially planned to sell a total of 2.5 mil. shares ("The Gray Sheet" Jan. 4, p. 11). Proceeds will be used for repayment of long-term debt, potential future acquisitions, and general corporate purposes.